Kimberly A. Skelding, MD, FACC, FAHA, FSCAI

The Resolute Stent: Three-Year Outcomes in Diabetics

08/01/2013

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

At the Society for Cardiovascular Angiography and Interventions (SCAI) annual Scientific Sessions in May 2013, Kimberly Skelding, MD, presented the three-year results of diabetic versus non-diabetic patients in the RESOLUTE US trial.

At the Society for...

08/01/2013

Cath Lab Digest

New Patient Placement Creates Safer Catheterizations for Morbidly Obese Patients

02/11/2010

Carissa Ridinger , RCIS;

Elizabeth Truxall , RCIS;

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

As America’s waistlines grow, there is an escalating rate of cardiac disease. With it comes the ever-increasing problem as to how to perform standard cardiac catheterizations on these patients. In Pennsylvania alone, 27.1% of the population...

As America’s waistlines grow,...

02/11/2010

Cath Lab Digest

Commentary

Evolving Use of Drug-eluting Stents in Diabetic Patients

08/01/2008

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

John J. Young , MD;

There are more than 150 million adults worldwide estimated to have diabetes mellitus (DM), with Type 2 diabetes accounting for up to 95% of all cases.1 In 2001, the prevalence of DM in the United States was 8%, a relative increase of...

There are more than 150 million...

08/01/2008

Journal of Invasive Cardiology

Case Report

Spontaneous Coronary Artery Dissection Related to Menstruation

08/01/2008

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

Cleon R. Hubbard , MD;

Coronary artery disease (CAD) has been recognized as the leading cause of mortality in women. Previously, it had been thought that estrogen provided a protective CAD effect, explaining the later development of disease in women. The Women’s...

Coronary artery disease (CAD)...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Feasibility and Safety of Ad Hoc Percutaneous Coronary Intervention in the Modern Era

05/04/2009

James C. Blankenship , MD;

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

Peter B. Berger , MD;

Christopher W. Good , DO;

G. Craig Wood ;

Thomas D. Scott , DO;

ABSTRACT: Background. The frequency of ad hoc percutaneous coronary intervention (PCI) varies among institutions and regions of the country. It is unclear what factors limit use of the ad hoc strategy. Objective. To define factors which limit...

ABSTRACT: Background. The...

05/04/2009

Journal of Invasive Cardiology

Clinical Editor's Corner

Conversations in Cardiology: Should a Lipid Panel Be Required Before Coronary Angiography or PCI?

08/22/2023

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Timothy D. Henry , MD;

George D. Dangas , MD, PhD;

Peter Ver Lee , MD;

Jeffrey W. Moses , MD;

Samuel M. Butman , MD;

Srihari S. Naidu , MD;

Phillip Mumford , MHA, MBA, RCIS;

Kreton Mavromatis , MD;

Ajay J. Kirtane , MD, SM;

Lloyd W. Klein , MD;

George W. Vetrovec , MD;

Dr. Ajay Kirtane asks, “I know of a couple of other places who do [pre-cath] lipid testing, but I think it is by far the exception rather than the rule. What are your thoughts?”

Dr. Ajay Kirtane asks, “I know...

08/22/2023

Cath Lab Digest

Validation of a Predictive Risk Score for Radiocontrast-Induced Nephropathy following Percutaneous Coronary Intervention

08/01/2008

William W. O'Neill , MD;

Charanjit S. Rihal , MD, MBA, FSCAI;

Kimberly A. Skelding , MD, FACC, FAHA, FSCAI;

Patricia J.M. Best , MD;

Beth A. Bartholomew , MD;

Ryan J. Lennon , MS;

Percutaneous diagnostic and therapeutic cardiovascular procedures rely on intravascular use of iodinated radiocontrast agents for visualization in the cardiac catheterization laboratory. The use of radiocontrast agents has been associated...

Percutaneous diagnostic and...

08/01/2008

Journal of Invasive Cardiology